Pancreas cancer, including patients at risk, as well as pancreatitis are among the most complex cases that physicians are confronted with as internists, gastroenterologists, oncologists, and surgeons. The Pancreas Symposium 2021 program reviews cutting-edge diagnostics and treatments as well as those on the horizon for pancreas diseases, both benign and malignant. This year’s program features renowned experts in pancreas cancer care, diagnostics and pancreatitis.
- Discuss chronic pancreatitis, including genetic risk factors and novel treatments, including endoscopic therapies and surgery
- Define standard of care treatment algorithms for pancreatic adenocarcinoma, including surgery, chemotherapy and radiation therapy
- Identify “new horizons” for improving survival in pancreatic adenocarcinoma, including when to consider clinical trials and immunotherapy, and when to recommend aggressive surgery
- Identify novel therapies for pancreatic ductal adenocarcinoma
- Describe the myriad of treatment guidelines for pancreas cystic neoplasms, as well as, explore diagnostic information on the horizon to further stratify risk and guide treatment
- Explain the role of genetics in pancreatic disease, both benign and malignant
This activity is designed for gastroenterologists, surgeons, internists, oncologists, radiologists, pathologists, RNs, PAs, NPs and other medical professionals involved in the evaluation, diagnosis and/or management of patients with benign and malignant pancreatic disease.
Method of Participation
After you register you will receive an email with a link to the webinar recording.